Cryodepleted plasma is used as an alternative to fresh frozen plasma (FFP) for plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP).
None.
Volume depends on local plasma exchange protocols and the patient’s weight with a 10–15 mL/kg dose recommended.
Cryodepleted plasma should be ABO compatible with the recipient's red cells.
Updated May 2025